Bristol-Myers Squibb Q2 Adj. EPS $2.04 Beats $1.59 Estimate, Sales $12.973B Beat $11.745B Estimate
Share
Why It Matters
Bristol-Myers Squibb made more money than people expected in the last three months. When a company beats its targets, it shows the business is doing well, so you might watch to see if they keep this up.
This read is generated by AI from raw market data and is for education only. It is not financial advice, not a signal, and not a recommendation to buy or sell.
Tickers in Play
Last session drawn · prints held ~15 minutes · licensed exchange data
Source: Benzinga · Read the original report at the publisher. Headline and figures shown for context; data may be delayed.
Disclosure: Educational and informational purposes only — not financial advice. We educate, not advise. Market data may be delayed up to 15 minutes unless marked real-time. Past performance is not indicative of future results.